Stacy Ronquillo
Stacy Ronquillo, MSN, APRN, FNP-BC, AGACNP-BC, IFMCP, ABAAHP
Endometriosis Long-Term Care Provider
Summary: Stacy Ronquillo is a dual board-certified Family Nurse Practitioner and Adult-Gerontology Acute Care Nurse Practitioner at Remedy Functional Medicine in Portland, Oregon. As an Endometriosis Long-Term Care and Chronic Care Provider, she specializes in individualized, comprehensive care for patients managing endometriosis and persistent pelvic pain.
Stacy takes a comprehensive, patient-centered approach to endometriosis care, recognizing that every patient’s experience is unique. She addresses hormonal, inflammatory, gastrointestinal, and nervous system factors that may contribute to symptoms. Her treatment approach may include medication management, nutritional support, pelvic floor physical therapy, and collaboration with endometriosis excision specialists when appropriate.
For patients experiencing persistent pain after surgery or struggling to find lasting symptom relief, Stacy provides ongoing support, thorough evaluations, and individualized care plans. She prioritizes listening to patients’ concerns, understanding their health goals, and helping them feel heard, informed, and supported throughout their endometriosis journey.
City: Portland, Oregon, USA
Accepting patients from Oregon, Washington, Nevada, and Kansas.
Practice model and additional information:
Philosophy of Endometriosis Care: I approach endometriosis as multifactorial, consistent with the current literature (Giudice 2010). No single theory explains every case. Retrograde menstruation accounts for much peritoneal disease but not for cases in people who have never menstruated or for distant lesions, where Müllerian rests and coelomic metaplasia offer better explanations. Genetic, epigenetic, and immune factors shape who develops disease and how it progresses. In practice, this means I don’t treat endometriosis as a uterine or purely hormonal problem. Lesions are endometrial-like tissue that can produce their own estrogen through aromatase and often show progesterone resistance, so hormonal suppression manages symptoms but does not remove disease. I refer for excision with a specialist when appropriate, and I address the inflammatory, immune, and central sensitization components alongside it through nutrition, GI evaluation, pelvic floor therapy, and trauma-informed mental health support.
Presurgical Care Plan: My pre-surgical care focuses on getting the patient to the right surgeon with the right information, and into surgery in the best possible condition. Surgical planning: I refer to an excision specialist and gather what the surgeon needs: a detailed symptom history with validated pain scores, prior operative and pathology reports, and imaging. When imaging hasn’t been done by someone experienced in endometriosis, I order expert transvaginal ultrasound or endometriosis-protocol MRI to map possible bowel, bladder, or deep disease so a multidisciplinary team (colorectal, urology) can be arranged in advance. Fertility: For patients who want future pregnancy, especially with endometriomas, I check AMH and discuss fertility preservation before surgery. Physiologic optimization: I screen for and correct iron deficiency and anemia, address blood sugar and nutritional status, and evaluate coexisting GI drivers such as SIBO or food sensitivities so post-op symptoms aren’t mistaken for persistent disease. Pelvic floor and pain: I refer to pelvic floor physical therapy before surgery to establish a baseline and begin addressing muscular contributors. I coordinate medication management, including whether to continue or pause hormonal suppression, according to the surgeon’s preference. Mental health and expectations: I offer trauma-informed psychological support, and I set realistic expectations: excision removes disease, but recovery takes time, and pain with central sensitization or pelvic floor components needs ongoing care after surgery.
Post-Surgical Care Plan: My post-surgical care focuses on recovery, interpreting what surgery found, and managing the components of pain that excision alone does not resolve. Early recovery: I see patients within the first few weeks to assess healing, bowel and bladder function (particularly after bowel or bladder procedures), and signs of complications. I coordinate with the surgeon on activity restrictions and use multimodal pain management with a plan to taper. Review of findings: I go over the operative and pathology reports with the patient so they understand where disease was found, what was removed, and what that means for their symptoms. For many patients, histologic confirmation is the first validation of years of symptoms. Hormonal management: For patients not trying to conceive, I discuss postoperative hormonal suppression to reduce recurrence of endometriomas and dysmenorrhea, choosing an option that fits their history, including any previous progestin non-response. Patients pursuing pregnancy go to a fertility plan instead, with timely REI referral when indicated. Pelvic floor and pain: Patients return to pelvic floor physical therapy once cleared by the surgeon. When pain persists after healing, I evaluate for central sensitization, pelvic floor dysfunction, adhesions, and GI drivers such as SIBO, rather than assuming surgery failed. Physiologic and psychological support: I continue nutritional support, iron repletion, and GI care, and maintain trauma-informed mental health support through recovery. Long-term follow-up: I track symptoms with the same validated pain scores used before surgery, so changes can be measured, and monitor for recurrence. For patients who had oophorectomy, I add screening for bone, cardiovascular, and cognitive risks and discuss hormone therapy.
Do you include imaging in pre-surgical planning? Yes, though imaging supports my approach rather than driving it. My diagnosis starts with the clinical picture: a detailed history of pain patterns, bowel, bladder, and sexual symptoms, cycle changes, and treatment response, built over time through a close patient-provider relationship. Because I see patients consistently and spend longer with them, I can track how symptoms evolve and respond to treatment, which often tells me more than a single study. When the clinical picture is consistent with endometriosis, I treat on that basis, rather than requiring imaging or surgical confirmation before patients get care. I offer imaging when it will change management: Transvaginal ultrasound is my first choice, ideally performed by a sonographer experienced in endometriosis using an advanced protocol. I use it to evaluate for endometriomas, deep infiltrating disease, and adenomyosis, and to monitor endometriomas over time. MRI with an endometriosis protocol is for inconclusive ultrasound, suspected deep disease, and surgical planning, so the surgeon knows in advance whether bowel, bladder, or ureteral involvement requires a multidisciplinary team. Renal ultrasound is for suspected disease near the ureters or bladder, since ureteral obstruction can progress without symptoms. I’m clear with patients that imaging cannot detect superficial peritoneal disease, so a normal result doesn’t rule out endometriosis or invalidate their symptoms. That’s where the relationship matters most: patients who have been told “your imaging is normal” for years need a provider who takes their history seriously.
Medication: I choose medications based on symptom pattern, reproductive goals, prior response, contraindications, and patient preference, and I’m clear with patients that medical therapy manages symptoms but does not remove disease. NSAIDs. First-line for dysmenorrhea, started a day or two before expected menses and taken on a schedule rather than as needed. Progestogens. These are the foundation of my hormonal management. For ovulation and symptom suppression, I primarily use progestins, including drospirenone (Slynd), norethindrone acetate, and the levonorgestrel IUD, chosen by side effect profile, bleeding pattern, and patient preference. Progestin-only options avoid estrogen-related risks, and drospirenone’s antimineralocorticoid and antiandrogenic properties make it well tolerated for many patients. I also use oral micronized progesterone for patients who don’t tolerate synthetic progestins due to mood or other side effects, or when sleep and luteal-phase symptoms are prominent, while being clear that its evidence for lesion suppression is more limited than for progestins. I reassess often, and if pain worsens or doesn’t improve, I consider progesterone resistance. Combined hormonal contraception. An option for select patients without contraindications to estrogen, used continuously. Second-line therapy. For patients who don’t respond to progestogen therapy, I coordinate with an endometriosis specialist or gynecologist for GnRH-based therapies, aromatase inhibitors, and surgical evaluation. Neuromodulators. Low-dose tricyclics or SNRIs when central sensitization is a significant contributor, alongside pelvic floor therapy and psychological support. Supportive therapies. Iron repletion for heavy bleeding, vitamin D correction, and evidence-informed anti-inflammatory support such as omega-3 fatty acids, as adjuncts rather than replacements for hormonal or surgical care. I avoid long-term opioids. For any hormonal option, I discuss fertility goals and, for gender-diverse patients, how progestogenic effects fit their goals and experience.
Approach to Persistent Pain After Surgery: I start by validating that persistent symptoms are real and common, and that they don’t mean the patient failed or the surgery was pointless. Then I work through why they’re happening, because persistent pain after surgery usually has more than one source. Timing. Healing and nerve recovery take months, so I distinguish expected recovery from true persistence, generally reassessing at three to six months against the patient’s pre-surgical baseline pain scores. Reviewing the surgery. I go back to the operative and pathology reports to understand what was found, whether lesions were excised or ablated, and whether any areas weren’t addressed. Incomplete excision, especially of deep disease, is a common reason symptoms continue. Broad differential. I evaluate for: Residual or recurrent endometriosis; adenomyosis, which excision of endometriosis does not treat; pelvic floor muscle dysfunction; central sensitization and neuropathic pain; pelvic congestion syndrome and other pelvic venous disorders, particularly when pain worsens with prolonged standing, late in the day, or after intercourse; postoperative adhesions; GI drivers such as SIBO, IBS, and food sensitivities; bladder pain syndrome; ovarian remnant in patients who had oophorectomy. Targeted management. Treatment follows what I find: pelvic floor physical therapy, neuromodulators and pain psychology for sensitization, GI evaluation and nutrition, and progestogen therapy to suppress residual or recurrent disease. When pelvic venous disease is suspected, I order transvaginal ultrasound with Doppler and refer to interventional radiology for venography and possible embolization. When residual endometriosis is likely, I refer back to an excision specialist with expert imaging, rather than toward repeated surgeries with non-specialists, which can add adhesions without resolving disease. Continuity. Because I follow patients closely over time, I can track which interventions change their symptoms and adjust accordingly, and patients have one provider coordinating care rather than navigating it alone.
What should be known about your practice? The structure of my new patient care is what sets my practice apart, and it was built for patients like those with endometriosis, who have usually spent years being seen in short visits by providers addressing one symptom at a time. Care begins with a 90-minute new patient visit focused on a full history: pain patterns, bowel, bladder, and sexual symptoms, cycle changes, prior surgeries and pathology, past treatment response, and the overlapping conditions that often travel with endometriosis. Patients then enter a six-month onboarding program designed to evaluate and stabilize the whole picture rather than one complaint. Over those six months, patients see me or a nurse practitioner I train and mentor about every six weeks, starting with a 90-minute visit to review comprehensive testing, which is included and selected for each patient (blood and stool testing based on their presentation). Registered dietitian visits fall between provider visits, so nutrition, GI, and inflammatory support are part of the treatment plan rather than a separate referral. Testing is repeated at three to four months to measure response, and patients have close monitoring in-between visits to track their cycles alongside symptoms. This cadence means imaging, specialist referrals, and medication changes happen in weeks, not months, and nothing is lost between visits. Endometriosis rarely presents alone in my panel. Many patients also have hypermobility spectrum disorders, mast cell activation, POTS, SIBO, PCOS/PMOS, and perimenopause, along with genitopelvic pain and sexual dysfunction, an area where I’ve completed additional advanced training. I’m a double board-certified nurse practitioner (FNP-BC, AGACNP-BC) with certification in functional medicine (IFMCP) and menopause care (MSCP), and more than 18 years of clinical experience, including over a decade as an emergency department nurse. My practice is licensed in Oregon, Washington, and Nevada, with in-person care in Portland. I’m not a surgeon. My role is diagnosis, medical management, pre- and post-surgical care, and timely referral to excision specialists. After onboarding, patients continue in membership care for ongoing management and surgical recovery. I also teach. I founded Remedy Meducation, which offers jointly accredited continuing education for clinicians, and serve as faculty with the Academy of Functional Nutrition & Lifestyle Medicine. I developed Filling in the Gaps™: Endometriosis & Chronic Pelvic Pain, The Multisystem Workup as a collaborative course with Dr. Lillian Medhus, DNP, WHNP-BC, CNM, MSCP, the first nurse practitioner listed on iCareBetter.
Kathy Kates
Kathy Kates, MSN, FNP-BC
Endometriosis Long Term Care Provider
Summary: Kathy Kates, MSN, FNP-BC, is an Endometriosis Long-Term Care Provider and founder of Pelvic Health Support in Brookline, Massachusetts, a clinical practice focused on restoring quality of life through integrative, evidence-based care for pelvic pain, sexual dysfunction, menopause, and endometriosis. She previously co-founded the Institute for Pelvic Health, where she developed continuing education programs to expand comprehensive pelvic health training for clinicians. Kathy holds a Master of Science in Nursing as a Family Nurse Practitioner from MGH Institute of Health Professions.
Kathy takes a multifactorial, whole-person approach to endometriosis, recognizing that the disease involves hormonal, inflammatory, immune, tissue, and nervous-system mechanisms. Her care may include individualized hormonal and pain management, pelvic floor therapy, myofascial and visceral therapies, and treatment of associated conditions such as mast cell activation, dysautonomia, and connective tissue disorders. She works closely with excision surgeons to prepare patients before surgery and provides structured postoperative care focused on healing, pelvic floor rehabilitation, bowel and bladder function, sexual health, symptom management, and long-term recurrence prevention.
Her philosophy is that endometriosis care extends beyond treating lesions alone. By addressing hormones, inflammation, tissue, muscle, and nervous-system sensitization together, Kathy aims to help patients reduce pain, restore function, and improve quality of life over the long term.
City: Brookline, Massachusetts, USA
Visit types: In-Person and Telehealth
Spoken languages: English
Interpreting services for other languages: No
Philosophy of Endometriosis Care: My approach reflects the current consensus that endometriosis is multifactorial. I regard Sampson’s retrograde menstruation theory as the foundational mechanism of lesion formation, but incomplete on its own: refluxed endometrial cells are found in the majority of menstruating women, yet only a subset develop disease. I therefore also ground my approach in the complementary theories – impaired immune clearance and chronic peritoneal inflammation, coelomic metaplasia, stem cell origin (including bone marrow-derived cells, which help explain recurrence after excision), and genetic/epigenetic predisposition. Because the disease is estrogen-dependent, inflammatory, and neuroimmunologic, my treatment model addresses hormones, tissue, and muscle together rather than treating the lesion alone.
Medication: My medication approach is layered to match the layered pathophysiology. Hormonal: continuous combined oral contraceptives or progestins for suppression; GnRH antagonists with add-back therapy for moderate-to-severe or refractory cases; and, in carefully selected refractory cases, aromatase inhibition. Pain and nervous system: NSAIDs for inflammatory flares, neuromodulators (gabapentin, low-dose amitriptyline) for sensitized pain, and low-dose naltrexone for its anti inflammatory and central sensitization effects. When MCAS overlaps, I use mast cell-directed therapy (H1/H2 blockade, cromolyn, ketotifen, microdosing of GLP/GIP). Locally: compounded topical hormones for tissue health: including vaginal estrogen +/- testosterone, neuropathic agents and vestibular or intravaginal onobotulinintoxinA for refractory high-tone dysfunction. For patients with metabolic or weight related comorbidity that is worsening their inflammatory burden and pain, I incorporate microdosed GLP-1/GIP receptor agonists – using low, titrated doses to capture the anti-inflammatory and metabolic benefits while minimizing GI side effects. Medication is always paired with bodywork and PT – drugs quiet the fire; they do not release the tissue.
Pre-surgical care plan: Before surgery, my goals are to decrease inflammation, calm the nervous system and optimize the tissue environment so the patient gets the most from the operation. I treat high-tone pelvic floor dysfunction and central sensitization preoperatively (pelvic floor therapy with myofascial release, visceral manipulation and – when indicated vestibular or intravaginal onobotulinintoxinA) so that postoperative pain is not layered onto a guarded, sensitized pelvis. I optimize the hormonal and inflammatory milieu, stabilize any comorbid mast cell activation, connective tissue disorder, dysautonomia, address bowel and bladder function, and coordinate timing and preoperative instructions with the excision surgeon. Just as importantly, I set expectations: surgery removes tissue, but it does not resolve muscle guarding, fascial restriction, or sensitization – so patients understand pre-surgical work is a crucial part of the overall treatment plan.
Post-surgical care plan: Postoperatively, I see patients early to support healing and prevent the pain cycle from restarting. The plan includes: (1) early hormonal suppression to reduce recurrence, given the estrogen dependent nature of lesions and the stem cell mechanism behind regrowth; (2) graded pelvic floor therapy once the surgeon clears it, to prevent guarding from becoming chronic high-tone dysfunction; (3) myofascial release and visceral mobilization after adequate healing to address adhesions, scar tissue, and fascial restriction, and restore visceral mobility; (4) bowel, bladder, and sexual function rehabilitation; and (5) structured follow-up to catch persistent symptoms early. I integrate the surgeon’s operative findings (disease extent, locations, complications) directly into the ongoing plan.
Imaging: When I have a high clinical suspicion for endometriosis—particularly with history or examination findings suggestive of deep infiltrating disease, such as uterosacral ligament nodularity, thickening of the posterior vaginal fornix, or dyspareunia, dysmenorrhea, and dyschezia—I refer directly to a trusted endometriosis excision surgeon rather than pursuing imaging myself. My reasoning is that a normal ultrasound or MRI does not rule out endometriosis: both modalities can reliably identify endometriomas and deep disease but frequently miss superficial peritoneal implants, and even expert readers can miss lesions because of their variable appearance and location. Any needed imaging is best obtained and interpreted as part of the surgeon’s preoperative planning. Consistent with the ACOG (2026) guideline, a clinical diagnosis based on symptoms and examination is sufficient to act on, so I also offer symptomatic patients empiric medical therapy in parallel while awaiting surgical evaluation— treatment is never delayed.
Approach to the persistent symptoms after surgery: Persistent postoperative symptoms mean it is time to reassess systematically, not to assume failure orreflexively repeat surgery. I work through a differential: residual or recurrent disease (targeted re-imaging or surgeon re-evaluation when indicated), myofascial dysfunction and fascial restriction from adhesions and scarring, persistent high-tone pelvic floor, central sensitization, and overlooked comorbidities such as MCAS, hEDS, bladder or bowel dysfunction. Treatment is matched to the finding: myofascial release and visceral mobilization for tissue restriction, pelvic floor rehabilitation for muscle guarding, hormonal adjustment for recurrent disease, LDN or neuromodulators for sensitization, and coordination with the surgeon for reoperation only when there is a clear target. Most persistent pain after excision is a muscle, fascia, or nervous system problem – and that is treatable.
Learn more: https://www.pelvichealthsupport.com/
Magen Price
Magen Price, FNP-BC, MSCP, CSC
Endometriosis Long-Term Care Provider
Summary: Magen Price is a Family Nurse Practitioner and skilled Long-Term Endometriosis Care Provider at Mystic Valley Sexual Wellness in Melrose, Massachusetts. She specializes in individualized, comprehensive care for endometriosis, with particular expertise in hormonal health, menopause, and sexual health. Her approach is evidence-informed and patient-centered, incorporating progestogens and oral contraceptives for endometriosis, as well as individualized hormonal therapy during the menopause transition, including oral micronized progesterone, estradiol, and, when appropriate, testosterone guided by ISSWSH recommendations. Pain management may also include analgesics, vaginal suppositories, and non-pharmacologic modalities.
Magen emphasizes comprehensive support throughout the surgical journey. Before surgery, she focuses on patient education, anticipatory guidance, and ensuring that patients have the appropriate emotional and practical supports in place. When possible, she collaborates closely with surgeons and values established relationships with excision specialists. Following surgery, she takes a hands-on approach to recovery, with particular attention to pain management during the first six months, monitoring for postoperative complications, and supporting patients as they begin pelvic floor physical therapy when appropriate. She also helps manage coexisting conditions, including mast cell activation syndrome and autoimmune disease, which may flare during the postoperative period.
Magen earned her Master of Science in Nursing (MSN) as a Family Nurse Practitioner from Simmons College in Boston in 2013 and her Bachelor of Arts in Biology and Psychology from Boston University in 2009. She is a Certified Family Nurse Practitioner through the American Nurses Credentialing Center (ANCC), a Registered Nurse in Massachusetts, a Menopause Society Certified Practitioner (MSCP), and an AASECT Certified Sex Counselor (CSC) and Approved Continuing Education Provider. Her professional affiliations include the International Society for the Study of Women’s Sexual Health (ISSWSH), where she serves on the Education Committee, as well as AASECT, The Menopause Society, the International Society for Mast Cell Activation Syndromes (ISMCAS), and the American Association of Nurse Practitioners (AANP).
City: Melrose, Massachusetts, USA
Visit types: In-Person and Telehealth
Spoken languages: English
Interpreting services for other languages: No
Philosophy of Endometriosis Care: While we aren’t married to any one theory, the polypotential germ-cell is probably at the forefront of our mind and dictates much of how we approach our patients.
Medication: Our practice is most focused on midlife care (though we have plenty of younger patients as well), so our expertise is really in hormonal treatments. For endometriosis we use progestogens and oral contraceptives, we use oral micronized progesterone, estradiol, and testosterone in the menopause transition (thoughtfully, per ISSWSH guidelines, and depending on the case). We have never needed to prescribe GnRH analogues in our practice. Pain management includes analgesics and vaginal suppositories, as well on non-pharmacologic modalities.
Pre-surgical care plan: Pre-surgery much of our focus is on patient support and anticipatory guidance. We work closely with surgeons (if possible). It is much easier when we have a relationship with their excision specialist. We help ensure supports are in place and all questions are answered.
Post-surgical care plan: Post-surgery we are much more hands-on. We focus on pain management for the first 6 months post-op, help with PFPT support when ready, and monitor for any post-surgical complications. We manage coexisting conditions such as MCAS or autoimmune disease which can flare post-surgery.
Lillian Medhus
Lillian Medhus, DNP, WHNP-BC, CNM, MSCP
Endometriosis Long Term Care Provider
Summary: Lillian Medhus, DNP, a Women’s Health Nurse Practitioner and skilled Long-Term Endometriosis Care Provider at Aspire Women’s Wellness. She specializes in comprehensive management of endometriosis, viewing it as a chronic, systemic neuroinflammatory condition and providing individualized, evidence-based care that addresses the whole person rather than focusing solely on gynecologic symptoms
Her comprehensive approach combines hormonal and non-opioid pain management, lifestyle and dietary interventions, metabolic health optimization, and treatment of coexisting conditions such as pelvic floor dysfunction, adenomyosis, migraines, IBS/IBD, hypermobility, MCAS, and mood disorders. She collaborates closely with surgeons, pelvic floor therapists, mental health providers, dietitians, and other specialists to support patients before and after surgery.
Lillian is a Menopause Society Certified Practitioner and holds certifications as a Certified Nurse Midwife, Women’s Health Nurse Practitioner, Certified Nurse Practitioner, and Registered Nurse. She earned her Doctor of Nursing Practice from Frontier Nursing University and her Master’s degree in Nurse Midwifery and Women’s Health Nurse Practitioner from Georgetown University, complemented by advanced training in trauma counseling.
City: Northfield, Minnesotta, USA
Visit types: In-Person (MN only) and Telehealth (throughout MN, TX, OK, and KS)
Spoken languages: English
Interpreting services for other languages: No
Philosophy of Endometriosis Care: Endometriosis is a chronic, neuroinflammatory condition that affects the entire body. The origin is likely genetic and pathophysiologic in nature, with an increased risk of symptoms in patients with other neuroimmune conditions. Treatment must look at the entire body, not isolated treatment of the gynecologic organs. Interventions to reduce inflammation and improve long-term health, include treatment of insulin resistance, nutrient deficiencies, consideration of the increased cardiovascular risks of endometriosis, and treatment of chronic overlapping pain conditions and central sensitization. Patients achieve the best outcomes with interdisciplinary care among surgeons, pelvic floor therapists, mental health providers, dieticians, long-term care providers, and other complementary therapies.
Medication: Progestogens: Progesterone, Drosperinone, Norethindrone acetate, Medroxyprogesterone. Progestogens are utilized for dysmenorrhea, menorrhagia, or chronic pelvic pain. Type of progestogen is based on patient preference, medication history, and pregnancy plans. I currently practice through telehealth only, however I may encourage a patient with suspected adenomyosis to pursue levonorgestrel IUD with their local GYN provider. Low dose naltrexone is utilized as an off-label option for chronic pain & inflammation. Vaginal suppositories (typically baclofen, with or without diazepam & gabapentin) are utilized for pain flares, sciatic pain, and hypertonic pelvic floor. Tirzepatide is used on-label for patients with insulin resistance, obesity, or metabolic disease. It is used off-label in small doses for inflammation. NSAIDs are utilized for pain. GnRH analogs are only used if the patient comes to our practice stable on them or as a bridge to surgery in very rare cases, and only as a final resort. Duavee/bazedoxifene may be an emerging option for endometriosis and menopause.
Pre-surgical care plan: Patients who are awaiting surgery, or who decline surgery, receive a holistic plan of care. New intake visits include a comprehensive lab panel, looking for any other causes of inflammation, fatigue, bloating, or other chronic symptoms which can be improved. Patients are referred to pelvic floor therapy in most cases, especially if there is evidence of pelvic floor dysfunction. Patients are also offered referral to mental health providers skilled in treatment of chronic disease. Patients are offered treatments including dietary interventions (ie- anti-inflammatory diet patterns & blood sugar management), evidence based supplement regimens, and non-opioid pain relief (including vaginal suppositories & NSAIDS). Collaborative care with the surgeon is utilized to make the decision whether to employ hormonal treatment options, or to defer until after surgery.
All the above is also utilized if a patient comes to me after surgery. Additionally, we will consider the use of hormonal options, most often progestogens. We will tailor treatment to any persistent symptoms, or other chronic overlapping conditions (MCAS, hypermobility, mood disorders, migraines, pelvic floor dysfunction, IBS/IBD, etc).
